Friction in the Path to Use of Biosimilar Drugs
N Engl J Med
.
2018 May 31;378(22):2148.
doi: 10.1056/NEJMc1805092.
Authors
Brian Chen
1
,
Y Tony Yang
2
,
Charles Bennett
Affiliations
1
University of South Carolina, Columbia, SC bchen@mailbox.sc.edu
2
George Mason University, Fairfax, VA
PMID:
29847904
DOI:
10.1056/NEJMc1805092
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal
Biosimilar Pharmaceuticals*
Friction*
Substances
Antibodies, Monoclonal
Biosimilar Pharmaceuticals